Spire Healthcare Group (LON:SPI) Trading Down 14.6% – Here’s Why

Spire Healthcare Group plc (LON:SPI) was down 14.6% during mid-day trading on Wednesday . The company traded as low as GBX 189.76 and last traded at GBX 190.80. Approximately 22,087,570 shares were traded during mid-day trading, an increase of 1,355% from the average daily volume of 1,518,252 shares. The stock had previously closed at GBX 223.50.

Analysts Set New Price Targets

Separately, JPMorgan Chase & Co. lowered their target price on shares of Spire Healthcare Group from GBX 309 to GBX 303 and set an “overweight” rating for the company in a research note on Tuesday, August 5th. Three investment analysts have rated the stock with a Buy rating, According to MarketBeat.com, Spire Healthcare Group presently has a consensus rating of “Buy” and an average price target of GBX 294.33.

Spire Healthcare Group Trading Down 14.8%

The firm’s 50-day moving average price is GBX 234.27 and its 200 day moving average price is GBX 222.02. The company has a market cap of £766.60 million, a price-to-earnings ratio of 41.42, a P/E/G ratio of 1.06 and a beta of 0.96. The company has a current ratio of 0.70, a quick ratio of 0.74 and a debt-to-equity ratio of 62.25.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.